FANas

Non-invasive point-of-care assessment device for airway inflammation that combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results including FeNO, CaNO, and FnNO in under one minute, with a patented dual-channel design that ensures complete protection against cross-contamination.

Carbon-13 breath test analyzer for non-invasive diagnosis of gastrointestinal disorders including H. pylori infection, small intestinal bacterial overgrowth, and lactose malabsorption. The device measures exhaled carbon-13 levels to assess metabolic function and intestinal health with rapid turnaround times.

A breath analysis device for multi-molecular, multi-site, multi-parameter testing of respiratory and digestive conditions with complications. The CA series includes inflammatory phenotyping breath testing with NO baseline plus CO and H2S optional configurations, supporting online standard, offline, and tidal breath modes. It features breath quality control with standard gas and self-calibration, and is applicable to respiratory, pediatric, otolaryngology, surgery, radiology, and health screening departments for conditions including asthma, COPD, interstitial lung disease, lung cancer, chronic cough, allergic rhinitis, sinusitis, nasal polyps, radiation pneumonitis, and perioperative pulmonary complications.

A breath diagnostic system that detects 13C-labeled CO2 in exhaled breath to diagnose Helicobacter pylori infection in the stomach.

Portable breath analyzer for measuring fractional exhaled nitric oxide (FeNO) levels, used in clinical assessment of airway inflammation and asthma management. The device provides rapid, non-invasive diagnostic testing suitable for point-of-care and home-based monitoring applications.

A breath analysis diagnostic system for measuring fractional exhaled nitric oxide levels, used to assess airway inflammation in respiratory diseases such as asthma. The platform integrates proprietary smart chip, smart algorithm, and smart manufacturing technologies for clinical and home-based testing.

A multi-molecular, multi-site, multi-parameter breath analysis system for detecting inflammation and related conditions. The CA series includes multiple configurations (CA3478, CA3138, CA4458) that measure various exhaled gases including NO, CO, H2S, CH4, CO2, and O2 in different combinations. It supports online and offline sampling modes with quality control features, and is designed for respiratory, pediatric, ENT, surgical, radiology, and physical examination departments to diagnose conditions such as asthma, COPD, interstitial lung disease, lung cancer, chronic cough, allergic rhinitis, sinusitis, and perioperative pulmonary complications.

An advanced breath analysis device for multi-molecular, multi-parameter inflammation and bacterial microbiota testing. The DA series includes configurations such as DA2123 with variable flow rate multi-parameter testing and DA7349 with NO, H2S, H2, CH4, CO, CO2, and O2 for comprehensive inflammation and microbiota breath testing plus AI olfactory diagnosis. It is designed for respiratory, digestive, allergy, and immunology departments for academic research and clinical applications including allergic rhinitis, asthma, irritable bowel syndrome, inflammatory bowel disease, colorectal cancer, and gut-lung, gut-heart, gut-liver, and gut-brain axis dysbiosis conditions.

A breath analysis system available in three configurations: CA3478 (NO+H2+CO2), CA3138 (NO+H2S+CO2), and CA4458 (NO+H2S+H2+CH4+CO2+O2) for combined assessment of inflammation and intestinal microbiota. The device is applicable in digestive and oral clinics, pediatrics, physical examinations, and allergy departments for diagnosis of conditions including irritable bowel syndrome, inflammatory bowel disease, colorectal cancer, Helicobacter pylori infection, functional dyspepsia, liver disease, halitosis, and allergic rhinitis/asthma.

An advanced multi-molecular breath analysis system featuring variable flow rate measurements and AI olfactory diagnostics. The DA series (DA2123 and DA7349 models) measures multiple exhaled gases including NO, H2S, H2, CH4, CO, CO2, and O2 for comprehensive inflammation and microbiota assessment. It is designed for respiratory, digestive, allergy, and immunology departments for academic research and high-level clinical services, addressing conditions related to microbiota imbalance and inflammation-related diseases.

The NObreath® FeNO device measures fractional exhaled nitric oxide (FeNO) to assess airway inflammation and aid in asthma diagnosis and management. This non-invasive breath test conforms to BTS/NICE/SIGN, ATS, and ERS guidelines and is suitable for both adult and pediatric patients. The device includes ambient NO monitoring capability for environmental assessment.

Integrated infrared analysis system for 13C urea breath testing, used for non-invasive diagnosis of Helicobacter pylori infection in gastroenterology. The system provides accurate measurement and analysis of isotope ratios in patient breath samples.